202 related articles for article (PubMed ID: 15003717)
1. Regulation of feeding by galnon.
Abramov U; Florén A; Echevarria DJ; Brewer A; Manuzon H; Robinson JK; Bartfai T; Vasar E; Langel U
Neuropeptides; 2004 Feb; 38(1):55-61. PubMed ID: 15003717
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
[TBL] [Abstract][Full Text] [Related]
3. Effect of galnon on induction of long-term potentiation in dentate gyrus of C57BL/6 mice.
Badie-Mahdavi H; Behrens MM; Rebek J; Bartfai T
Neuropeptides; 2005 Jun; 39(3):249-51. PubMed ID: 15944018
[TBL] [Abstract][Full Text] [Related]
4. Chronic activity wheel running reduces the severity of kainic acid-induced seizures in the rat: possible role of galanin.
Reiss JI; Dishman RK; Boyd HE; Robinson JK; Holmes PV
Brain Res; 2009 Apr; 1266():54-63. PubMed ID: 19248773
[TBL] [Abstract][Full Text] [Related]
5. Galnon--a low-molecular weight ligand of the galanin receptors.
Sollenberg U; Bartfai T; Langel U
Neuropeptides; 2005 Jun; 39(3):161-3. PubMed ID: 15944006
[TBL] [Abstract][Full Text] [Related]
6. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption.
Parrado C; Díaz-Cabiale Z; García-Coronel M; Agnati LF; Coveñas R; Fuxe K; Narváez JA
Neuropharmacology; 2007 Feb; 52(2):684-92. PubMed ID: 17087983
[TBL] [Abstract][Full Text] [Related]
7. Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the rat.
Kuteeva E; Wardi T; Hökfelt T; Ogren SO
Eur Neuropsychopharmacol; 2007 Jan; 17(1):64-9. PubMed ID: 16624535
[TBL] [Abstract][Full Text] [Related]
8. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effects of intracerebroventricular injection of the galanin receptor 1 agonist M 617 in rats.
Fu LB; Wang XB; Jiao S; Wu X; Yu LC
Neurosci Lett; 2011 Mar; 491(3):174-6. PubMed ID: 21241771
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant activity of a nonpeptide galanin receptor agonist.
Saar K; Mazarati AM; Mahlapuu R; Hallnemo G; Soomets U; Kilk K; Hellberg S; Pooga M; Tolf BR; Shi TS; Hökfelt T; Wasterlain C; Bartfai T; Langel U
Proc Natl Acad Sci U S A; 2002 May; 99(10):7136-41. PubMed ID: 12011470
[TBL] [Abstract][Full Text] [Related]
11. Differential inhibition of galanin- and ghrelin-induced food intake by i.c.v. GLP-1(7-36)-amide.
Schusdziarra V; Zimmermann JP; Erdmann J; Bader U; Schick RR
Regul Pept; 2008 Apr; 147(1-3):29-32. PubMed ID: 18281111
[TBL] [Abstract][Full Text] [Related]
12. Multiple interaction sites of galnon trigger its biological effects.
Florén A; Sollenberg U; Lundström L; Zorko M; Stojan J; Budihna M; Wheatley M; Martin NP; Kilk K; Mazarati A; Bartfai T; Lindgren M; Langel U
Neuropeptides; 2005 Dec; 39(6):547-58. PubMed ID: 16297447
[TBL] [Abstract][Full Text] [Related]
13. The role of the galaninergic system in modulating stress-related responses in an animal model of posttraumatic stress disorder.
Kozlovsky N; Matar MA; Kaplan Z; Zohar J; Cohen H
Biol Psychiatry; 2009 Mar; 65(5):383-91. PubMed ID: 19095221
[TBL] [Abstract][Full Text] [Related]
14. Intracerebroventricular administration of galanin antagonist sustains insulin resistance in adipocytes of type 2 diabetic trained rats.
Zhang Z; Sheng S; Guo L; Li G; Zhang L; Zhang L; Shi M; Bo P; Zhu Y
Mol Cell Endocrinol; 2012 Sep; 361(1-2):213-8. PubMed ID: 22564511
[TBL] [Abstract][Full Text] [Related]
15. Binding and agonist/antagonist actions of M35, galanin(1-13)-bradykinin(2-9)amide chimeric peptide, in Rin m 5F insulinoma cells.
Kask K; Berthold M; Bourne J; Andell S; Langel U; Bartfai T
Regul Pept; 1995 Nov; 59(3):341-8. PubMed ID: 8577939
[TBL] [Abstract][Full Text] [Related]
16. Central administration of galanin stimulates feeding behavior in chicks.
Tachibana T; Mori M; Khan MS; Ueda H; Sugahara K; Hiramatsu K
Comp Biochem Physiol A Mol Integr Physiol; 2008 Dec; 151(4):637-40. PubMed ID: 18725311
[TBL] [Abstract][Full Text] [Related]
17. Administration of the galanin antagonist M40 into lateral septum attenuates shock probe defensive burying behavior in rats.
Echevarria DJ; Hernandez A; Diogenes A; Morilak DA
Neuropeptides; 2005 Oct; 39(5):445-51. PubMed ID: 16084587
[TBL] [Abstract][Full Text] [Related]
18. The galanin receptor agonist, galnon, attenuates cocaine-induced reinstatement and dopamine overflow in the frontal cortex.
Ogbonmwan YE; Sciolino NR; Groves-Chapman JL; Freeman KG; Schroeder JP; Edwards GL; Holmes PV; Weinshenker D
Addict Biol; 2015 Jul; 20(4):701-13. PubMed ID: 25053279
[TBL] [Abstract][Full Text] [Related]
19. Systemic galnon, a low-molecular weight galanin receptor agonist, reduces heat hyperalgesia in rats with nerve injury.
Wu WP; Hao JX; Lundström L; Wiesenfeld-Hallin Z; Langel U; Bartfai T; Xu XJ
Eur J Pharmacol; 2003 Dec; 482(1-3):133-7. PubMed ID: 14660014
[TBL] [Abstract][Full Text] [Related]
20. Galanin, through GalR1 but not GalR2 receptors, decreases motivation at times of high appetitive behavior.
Anderson ME; Runesson J; Saar I; Langel U; Robinson JK
Behav Brain Res; 2013 Feb; 239():90-3. PubMed ID: 23142608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
